IMST for Dementia Risk Reduction

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-80
SponsorFlorida State University

About this trial

Using a 2-arm, RCT approach, the primary goal of the study is to evaluate the feasibility and preliminary efficacy of Inspiratory Muscle Strength Training (IMST) as a non-pharmacologic intervention to reduce cardiovascular and cognitive risks in older adults. Next, investigators will examine secondary effects of IMST on mood, sleep quality, systemic inflammation, and physical/motor function. Finally, investigators will assess participant adherence and acceptability ratings of using an 8-week home-based IMST protocol in a diverse older adult sample.

Eligibility criteria

Qualifiers

Ages 60-80

Converted telephone MoCA total score≥18

Presence of at least one dementia risk factor (e.g., MCI or subjective cognitive decline, hypertension [SBP >130 mmHg or on medication], sedentary lifestyle [<150 min/week], family history of dementia or self-reported APOE ε4 carrier, or mild sleep-disordered breathing; CAIDE total score [>5]

Capable of independently completing or requiring minimal assistance with inspiratory muscle strength training (IMST)

Disqualifiers

tMoCA <18, or diagnosis of neurodegenerative illness at the discretion of principal investigator (except MCI)

Current evidence of any major psychiatric disorder including psychosis (at the discretion of principal investigator), bipolar disorder, severe major depression (PHQ-9 > 20)

Unstable cardiovascular or pulmonary disease

Recent respiratory therapy or major medication changes

Trial design

Treatments tested in this trial

  • Inspiratory Muscle Strength Training High-Resistance
  • Inspiratory Muscle Strength Training Low-Resistance

Treatment groups

30 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Florida State University

Lead sponsor

National Institutes of Health (NIH)

Collaborator